Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 24 (Search time: 0.01 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Variable effects on lipid transporting and non-lipid transporting functions of HDL in young patients with chronic inflammatory arthritisMani, P.; Uno, K.; Duong, M.; Wolski, K.; Spalding, S.; Husni, E.; Nicholls, S.; American Heart Association 2013 Scientific Sessions and Resuscitation Science Symposium (16 Nov 2013 - 17 Nov 2013 : Dallas, TX)
2013Factors underlying regression of coronary atheroma with potent statin therapyPuri, R.; Nissen, S.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; St. John, J.; Wolski, K.; Uno, K.; Kataoka, Y.; Nicholls, S.
2013Exploring coronary atherosclerosis with intravascular imagingPuri, R.; Tuzcu, E.; Nissen, S.; Nicholls, S.
2013Coronary atheroma volume and cardiovascular events during maximally intensive statin therapyPuri, R.; Nissen, S.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
2013Effect of aliskiren on progression of coronary disease in patients with prehypertension: The AQUARIUS randomized clinical trialNicholls, S.; Bakris, G.; Kastelein, J.; Menon, V.; Williams, B.; Armbercht, J.; Brunel, P.; Nicolaides, M.; Hsu, A.; Hu, B.; Fang, H.; Puri, R.; Uno, K.; Kataoka, Y.; Bash, D.; Nissen, S.
2013Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy - a meta-analysis of 11 randomized controlled trials involving 21,295 participantsBarylski, M.; Nikfar, S.; Mikhailidis, D.; Toth, P.; Salari, P.; Ray, K.; Pencina, M.; Rizzo, M.; Rysz, J.; Abdollahi, M.; Nicholls, S.; Banach, M.
2013Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute st-segment elevation myocardial infarctionMadder, R.; Goldstein, J.; Madden, S.; Puri, R.; Wolski, K.; Hendricks, M.; Sum, S.; Kini, A.; Sharma, S.; Rizik, D.; Brilakis, E.; Shunk, K.; Petersen, J.; Weisz, G.; Virmani, R.; Nicholls, S.; Maehara, A.; Mintz, G.; Stone, G.; Muller, J.
2013A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial)Maki, K.; Orloff, D.; Nicholls, S.; Dunbar, R.; Roth, E.; Curcio, D.; Johnson, J.; Kling, D.; Davidson, M.
2013Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trialLincoff, M.; Tardif, J.; Neal, B.; Nicholls, S.; Ryden, L.; Schwartz, G.; Malmberg, K.; Buse, J.; Henry, R.; Wedel, H.; Weichert, A.; Cannata, R.; Grobbee, D.
2013C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapyPuri, R.; Nissen, S.; Libby, P.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.